Lastacaft (alcaftadine ophthalmic) is filed as Ophthalmic Antihistamine. The sections below restate public label fields stored for this profile.
1 INDICATIONS AND USAGE LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. ( 1 )
12.1 Mechanism of Action Alcaftadine is an H 1 histamine receptor antagonist and inhibitor of the release of histamine from mast cells. Decreased chemotaxis and inhibition of eosinophil activation has also been demonstrated.
5 WARNINGS AND PRECAUTIONS To minimize the risk of contamination, do not touch dropper tip to any surface. Keep bottle tightly closed when not in use. ( 5.1 ) LASTACAFT™ should not be used to treat contact lens-related irritation. ( 5.2 ) Remove contact lenses prior to instillation of LASTACAFT™ . ( 5.2 ) 5.1 Contamination of Tip and Solution To minimize contaminating the dropper tip and solution, care should be taken not to touch the eyelids or surrounding areas with the dropper tip of the bottle. Keep bottle tightly closed when not in use. 5.2 Contact Lens Use Patients should be advised not to wear a contact lens if their eye is red. LASTACAFT™ should not be used to treat contact lens-related irritation. LASTACAFT™ should not be instilled while wearing contact lenses. Remove contact lenses prior to instillation of LASTACAFT™ . The preservative in LASTACAFT™ , benzalkonium chloride, may be absorbed by soft contact lenses. Lenses may be reinserted after 10 minutes following administration of LASTACAFT™ . 5.3 Topical Ophthalmic Use Only LASTACAFT™ is for topical ophthalmic use only.
4 CONTRAINDICATIONS LASTACAFT ® is contraindicated in patients with hypersensitivity to any component in the product. Hypersensitivity ( 4 )
2 DOSAGE AND ADMINISTRATION Instill one drop in each eye once daily. If more than 1 topical ophthalmic medicinal product is being used, each one should be administered at least 5 minutes apart. Instill one drop in each eye once daily. ( 2 )
According to its FDA label, Lastacaft (alcaftadine ophthalmic) is approved for: 1 INDICATIONS AND USAGE LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. LASTACAFT ® is an H 1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjun… For medical advice, please talk to your prescriber or pharmacist.
Lastacaft (alcaftadine ophthalmic) belongs to the Ophthalmic Antihistamine class of medications.
The FDA label lists Lastacaft (alcaftadine ophthalmic) as: 3 DOSAGE FORMS AND STRENGTHS Ophthalmic solution containing alcaftadine 0.25% (2.5 mg/mL). Ophthalmic solution containing alcaftadine 0.25% (2.5 mg/mL) ( 3 ); ophthalmic route. Available strengths and packaging vary by manufacturer.
Our ingest of the FDA label for Lastacaft (alcaftadine ophthalmic) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Lastacaft (alcaftadine ophthalmic) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Lastacaft (alcaftadine ophthalmic) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA record lists the approval date for Lastacaft (alcaftadine ophthalmic) as 2010-07-28.
The FDA label lists Allergan, Inc. as a labeler/manufacturer of Lastacaft (alcaftadine ophthalmic). Multiple firms may market generics of the same molecule.
The FDA label states: "LASTACAFT ® (alcaftadine ophthalmic solution) 0.25% is supplied in an opaque, white low-density polyethylene bottle with a white polystyrene cap. 3 mL fill in 5 mL bottle NDC 0023-4290-03 Storage: Store at 15°C to 25°C (…" Follow the packaging insert for the authoritative guidance.
Loading full data from Know Your Drugs Institute…